-+ 0.00%
-+ 0.00%
-+ 0.00%

OnKure Therapeutics Q1 EPS $(1.19) Beats $(1.46) Estimate

Benzinga·05/06/2025 11:47:29
Listen to the news
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(1.19) per share which beat the analyst consensus estimate of $(1.46) by 18.49 percent.